Carl Dockery

CIK: 0001618149

Transaction Breakdown

Open Market Buys (P)1 (20.0%)

High conviction signal

Open Market Sales (S)1 (20.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (60.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

AYTU

AYTU BIOPHARMA, INC

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

AYTU
AYTU BIOPHARMA, INC
Jul 28, 2026
Award(A)
Direct
10K shares-
AYTU
AYTU BIOPHARMA, INC
Oct 3, 2025
Award(A)
Direct
10K shares-
AYTU
AYTU BIOPHARMA, INC
Nov 6, 2024
Award(A)
Direct
1.5K shares-
AYTU
AYTU BIOPHARMA, INC
Dec 30, 2020
Sale(S)
Indirect
209 shares at avg. $6.01$1K
AYTU
AYTU BIOPHARMA, INC
Nov 18, 2020
Purchase(P)
Indirect
10K shares at avg. $0.92$9K

		Type	Shares	Price		Ownership
Jul 28, 2026	AYTU AYTU BIOPHARMA, INC	Award(A)	10,000	-	$0	Direct
Oct 3, 2025	AYTU AYTU BIOPHARMA, INC	Award(A)	10,000	-	-	Direct
Nov 6, 2024	AYTU AYTU BIOPHARMA, INC	Award(A)	1,500	-	$0	Direct
Dec 30, 2020	AYTU AYTU BIOPHARMA, INC	Sale(S)	209	$6.01	$1,256	Indirect
Nov 18, 2020	AYTU AYTU BIOPHARMA, INC	Purchase(P)	10,000	$0.92	$9,230	Indirect

1-5 of 5 transactions

About DOCKERY CARL

DOCKERY CARL (SEC CIK 0001618149) files insider reports with the SEC as Director of AYTU BIOPHARMA, INC (AYTU).

Signal8 holds 4 ownership filings by DOCKERY CARL (3 Form 4, 1 Form 5), filed between Nov 8, 2024 and Jul 30, 2026. Those filings report 5 transactions, from Nov 18, 2020 to Jul 28, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on DOCKERY CARL's filings is in DENVER, CO.

Recent filings by DOCKERY CARL

Jul 28, 2026: Grant or award of AYTU shares (Form 4, code A).
Oct 3, 2025: Grant or award of AYTU shares (Form 4, code A).
Nov 6, 2024: Grant or award of AYTU shares (Form 4, code A).
Dec 30, 2020: Open-market sale of AYTU shares (Form 5, code S).
Nov 18, 2020: Open-market purchase of AYTU shares (Form 5, code P).

Other insiders filing for AYTU BIOPHARMA, INC (AYTU)

Disbrow Joshua R., Chief Executive Officer
PYSZCZYMUKA GREG, Chief Commercial Officer
Disbrow Jarrett, Chief Business Officer
Selhorn Ryan J, Chief Financial Officer
LIU VIVIAN H, Director
JAIN ABHINAV, Director

How to read Form 4 transaction codes